Immunogenicity and Safety Profile of Typhoid Conjugate Vaccine (Vi-DT) Among Nepali Children
The overall seroconversion in Vi DT vaccine was non inferior to the comparator vaccine and the safety profile of the vaccine was good without any life-threatening events.
Authors
- Ram Hari Chapagain (ORCID: https://orcid.org/0000-0001-5939-5471)
- Bishnu Rath Giri (ORCID: https://orcid.org/0000-0001-5238-2061)
- Nisha Jyoti Shrestha
- Deok Ryun Kim (ORCID: https://orcid.org/0009-0007-3085-6773)
- Santosh Adhikari
- Suresh Man Tamang
- Bina Prajapati Manandhar
- Birendra Prasad Gupta (ORCID: https://orcid.org/0000-0001-6477-6260)
- Sushant Sahastrabuddhe (ORCID: https://orcid.org/0000-0003-1751-3905)
- Sridhar Vemula (ORCID: https://orcid.org/0000-0002-0882-101X)
- Jessica Maharjan
- Tarun Saluja (ORCID: https://orcid.org/0000-0001-9771-7021)
- Prakash Joshi (ORCID: https://orcid.org/0000-0002-9488-6222)
- Ganesh Kumar
- Bibesh Thapaliya
Institutions
- International Vaccine Institute (KR)
- National Hospital (IN)
- Kanti Children's Hospital (NP)
Publication Details
- Journal
- Journal of Nepal Health Research Council
- Published
- 2025-06-29
- DOI
- https://doi.org/10.33314/jnhrc.v23i01.5251
- Primary Topic
- Viral gastroenteritis research and epidemiology
- Type
- article
- Field-Weighted Citation Impact
- 0.00